From: www.ecancer.tv on Thu, Nov 04 2010 3:19 PM

Dr. Natalia Zakharova discusses her ESMO funded research evaluating the Eastern Europe breast cancer screening programme, a programme that aims to improve the quality of breast screening. Dr. Zakharova goes on to speak about a randomised trial she will be conducting which will compare mammograph...

From: www.ecancer.tv on Mon, Nov 01 2010 3:41 PM

Dr Simona Grozinsky-Glasberg speaks about her work with neuroendocrine tumours and explains why she believes that investigating mTOR will be an important step towards developing a successful treatment. Dr Grozinsky-Glasberg discusses the current standard treatment for these tumours, outlines the...

From: www.ecancer.tv on Mon, Nov 01 2010 2:40 PM

Dr Joost Nuyttens speaks about Cyberknife, explaining which cancers can be treated with this technology and how patients are selected. The benefits include the relatively small number of hospital visits required and the ability to track the tumour, ensuring that healthy tissue is not irradiated ...

From: www.ecancer.tv on Mon, Nov 01 2010 1:39 PM

Prof Nicholas Pavlidis speaks about the effects, prevalence and best ways of detecting and treating cancer of unknown primary origin (CUP). Prof Pavlidis stresses the importance of a correct diagnosis and explains the differences in treatment for CUP depending on the patient’s prognosis.

From: www.ecancer.tv on Mon, Nov 01 2010 12:39 PM

Due to the improvements in cancer treatment, more and more people are surviving therapy. Prof Wim van Harten speaks about the importance of dealing with the symptoms and problems experienced after treatment and talks about the upcoming OECI meeting which will address this issue. Prof van Harten ...

From: www.ecancer.tv on Fri, Oct 29 2010 12:06 PM

Dr Renata Auriemma speaks about research comparing the short and long term affects of the GH receptor antagonist pegvisomant on acromegaly patient cardiac rhythm. Dr Auriemma explains how pegvisomant works and outlines how the study has shown that although short term use has no significant effect...

From: www.ecancer.tv on Thu, Oct 28 2010 11:02 AM

Prof Pierre-Yves Bondiau speaks to ecancer.tv about his research into the use of CyberKnife to treat lung cancer. This radiosurgery tool allows radiation to be targeted extremely accurately and tracks tumours as they move with the breathing movement of the lung. Because the CyberKnife can accurat...

From: www.ecancer.tv on Fri, Oct 22 2010 2:09 PM

The managing editor of ecancer gives his highlights from ESMO 2010, Milan 8-12th October 2010.

From: www.ecancer.tv on Fri, Oct 22 2010 12:37 PM

Breast sarcoma is a very rare, difficult to manage disease. The Royal Marsden’s experience is reported here from ESSO 2010 in Bordeaux: 63 angiosarcoma patients evaluated for outcome. Call for centralizing care in such rare cancers, and different management style required.

From: www.ecancer.tv on Thu, Oct 21 2010 9:34 PM

Lynda Wyld, Bert Bonsing & Pierre Mordant speak to ecancer.tv about the highlights from the ESSO 2010 meeting. These include talks addressing over-treatment in breast cancer, the importance of good management of the operating theatre, lung cancer in elderly patients, new surgical imaging technol...

From: www.ecancer.tv on Thu, Oct 21 2010 7:33 PM

Dr Graeme Poston speaks to ecancer.tv about the challenges faced when trying to maintain a constantly high standard of surgery across the UK. Although progress has been made ensuring that surgeons are properly trained and working in well equipped specialised units there are still too much variati...

From: www.ecancer.tv on Thu, Oct 21 2010 7:33 PM

Managing editor Prof Gordon McVie, from the European Institute of Oncology, speaks to Prof Jean-Yves Blay at ESSO 2010, Bordeaux, about the role of the European Organisation for Research and Treatment of Cancer (EORTC). Issues such as a decrease in applications for clinical trials, translational...

From: www.ecancer.tv on Thu, Oct 21 2010 6:52 PM

Prof Dirk Gouma speaks about his research comparing the use of endoscopic stents with bypass surgery for patients with pancreatic cancer. This study found that patients with a short life expectancy benefited from the short hospital stay and rapid recovery associated with an endoscopic stent where...

From: www.ecancer.tv on Thu, Oct 14 2010 12:03 PM

Peter Goodwin speaks to Professor Pat Whitworth about the differences between genomic classifiers, details of the Oncotype DX classifier, establishing which patients require which treatment, gene arrays

From: www.ecancer.tv on Wed, Oct 06 2010 7:05 PM

Prof Catherine West speaks to ecancer.tv about the radiogenomics consortium. This consortium is a large-scale international pool of genetic data introduced to allow clinicians to predict individual patient response to radiotherapy. Prof West discusses what the project is aiming to achieve, how d...

From: www.ecancer.tv on Wed, Oct 06 2010 6:12 PM

Prof Roberto Orecchia talks about techniques and options regarding partial breast irradiation and related issues that have arisen at ESTRO 2010. Prof Orecchia discusses what conclusions can be drawn from clinical trials investigating partial breast irradiation and what further work is necessary b...

From: www.ecancer.tv on Wed, Oct 06 2010 6:09 PM

Prof Hans Peter Rodemann speaks about his work investigating how inhibition of the EGFR pathway induces resistance to radiotherapy in tumour cells. This research has shown that this signalling pathway induces resistance by activating DNA repair mechanisms. The EGFR receptors are themselves activa...

From: www.ecancer.tv on Wed, Oct 06 2010 5:51 PM

Prof Richard Pötter talks to ecancer.tv about recent advances in gynaecological radiotherapy. The integration of imaging technology into brachytherapy allows the use of much higher doses and for treatment to be targeted more accurately at cancer cells. Prof Pötter outlines the difficulties fundin...

From: www.ecancer.tv on Wed, Oct 06 2010 5:50 PM

Stephanie Lang discusses a clinical trial investigating the use of TrueBeam to deliver hyperfractionated treatment to small tumours in the brain and lung. TrueBeam is a new radiosurgery technology that can image patients and deliver a dose of radiation to large or small tumours very quickly and a...

From: www.ecancer.tv on Wed, Oct 06 2010 5:39 PM

Prof Harry Bartelink speaks about his work with breast conserving therapy and suggests an explanation for data showing that young women with breast cancer have a worse prognosis than older breast cancer patients. Prof Bartelink speaks about developments that help oncologists predict which treatme...